A Multicenter, Prospective Non-interventional Study to Evaluate the Quality of Life in Belgian Patients With CIS or RRMS in Whom Interferon Beta-1a IM Treatment Has Been Initiated
Phase of Trial: Phase IV
Latest Information Update: 24 Oct 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms AVAIL
- Sponsors Biogen
- 16 Oct 2015 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 02 Jun 2015 Planned End Date changed from 1 Dec 2012 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 02 Jun 2015 Planned primary completion date changed from 1 Dec 2012 to 1 Sep 2015 as per ClinicalTrials.gov record.